1. Home
  2. MAIR vs HALO Comparison

MAIR vs HALO Comparison

Compare MAIR & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Madison Air Solutions Corporation Class A Common Stock

MAIR

Madison Air Solutions Corporation Class A Common Stock

HOLD

Current Price

$22.67

Market Cap

12.2B

Sector

Industrials

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$126.21

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAIR
HALO
Founded
1994
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Pollution Control Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.2B
12.0B
IPO Year
2026
2001

Fundamental Metrics

Financial Performance
Metric
MAIR
HALO
Price
$22.67
$126.21
Analyst Decision
Strong Buy
Buy
Analyst Count
11
9
Target Price
$38.67
★ $108.78
AVG Volume (30 Days)
★ 2.2M
2.2M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
0.26
★ 3.11
Revenue
N/A
★ $151,862,000.00
Revenue This Year
$18.72
$34.69
Revenue Next Year
$14.03
$11.65
P/E Ratio
$88.81
★ $39.88
Revenue Growth
N/A
N/A
52 Week Low
$21.96
$61.23
52 Week High
$41.89
$125.43

Technical Indicators

Market Signals
Indicator
MAIR
HALO
Relative Strength Index (RSI) 35.45 74.21
Support Level N/A $105.27
Resistance Level $25.55 N/A
Average True Range (ATR) 0.91 3.51
MACD 0.01 1.11
Stochastic Oscillator 24.39 99.04

Price Performance

Historical Comparison
MAIR
HALO

About MAIR Madison Air Solutions Corporation Class A Common Stock

Madison Air Solutions Corp is an HVAC and indoor air-quality technology company. Its segments are Commercial and Residential. It generates the majority of its revenue from the Commercial segment, which includes Commercial businesses that deliver well-engineered, custom, and semi-custom air quality systems to support process control, regulatory compliance, energy efficiency, and productivity in mission-critical environments; and the Residential segment, anchored by trusted brands like AprilAire, Broan-NuTone, Zephyr, and Others. Its geographic areas are the U.S, the Americas, Europe, and Other. The group generates the majority of its revenue from the U.S market.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: